PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347 | -11.3% | 33,507 | +12.6% | 0.00% | – |
| Q2 2023 | $391 | +30.3% | 29,758 | +11.1% | 0.00% | – |
| Q1 2023 | $300 | +36.4% | 26,795 | +2.6% | 0.00% | – |
| Q4 2022 | $220 | -99.9% | 26,104 | +2.8% | 0.00% | – |
| Q3 2022 | $424,000 | +23.3% | 25,396 | +8.7% | 0.00% | – |
| Q2 2022 | $344,000 | -34.0% | 23,363 | +11.3% | 0.00% | – |
| Q1 2022 | $521,000 | -23.3% | 20,986 | -0.9% | 0.00% | – |
| Q4 2021 | $679,000 | -95.4% | 21,183 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $14,802,000 | -13.9% | 411,387 | +5.6% | 0.00% | -50.0% |
| Q2 2021 | $17,186,000 | -47.7% | 389,527 | -45.7% | 0.00% | -33.3% |
| Q1 2021 | $32,838,000 | +28.6% | 717,923 | +94.1% | 0.00% | 0.0% |
| Q4 2020 | $25,532,000 | – | 369,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |